NDC 60505-2901

Imatinib Mesylate

Imatinib Mesylate

Imatinib Mesylate is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp. The primary component is Imatinib Mesylate.

Product ID60505-2901_2b5038bb-d4ca-f904-34d9-b962db87f3ba
NDC60505-2901
Product TypeHuman Prescription Drug
Proprietary NameImatinib Mesylate
Generic NameImatinib Mesylate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2016-08-05
Marketing CategoryANDA / ANDA
Application NumberANDA079179
Labeler NameApotex Corp
Substance NameIMATINIB MESYLATE
Active Ingredient Strength400 mg/1
Pharm ClassesKinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 60505-2901-0

10 BLISTER PACK in 1 CARTON (60505-2901-0) > 10 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Start Date2016-08-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60505-2901-3 [60505290103]

Imatinib Mesylate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA079179
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-08-05

NDC 60505-2901-0 [60505290100]

Imatinib Mesylate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA079179
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-08-05

NDC 60505-2901-7 [60505290107]

Imatinib Mesylate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA079179
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-08-05
Marketing End Date2016-08-05

NDC 60505-2901-5 [60505290105]

Imatinib Mesylate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA079179
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-08-05

NDC 60505-2901-1 [60505290101]

Imatinib Mesylate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA079179
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-08-05

NDC 60505-2901-9 [60505290109]

Imatinib Mesylate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA079179
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-08-05

Drug Details

Active Ingredients

IngredientStrength
IMATINIB MESYLATE400 mg/1

OpenFDA Data

SPL SET ID:0291eca5-7a1d-4a79-30be-252224d96509
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 403878
  • 403879

    • Pharmacological Class

    • Kinase Inhibitor [EPC]
    • Protein Kinase Inhibitors [MoA]

    Medicade Reported Pricing

    60505290103 IMATINIB MESYLATE 400 MG TAB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Imatinib Mesylate" or generic name "Imatinib Mesylate"

    NDCBrand NameGeneric Name
    0054-0248Imatinib MesylateImatinib Mesylate
    0054-0249Imatinib MesylateImatinib Mesylate
    0093-7629Imatinib MesylateImatinib Mesylate
    0093-7630Imatinib MesylateImatinib Mesylate
    0378-2245Imatinib Mesylateimatinib
    0378-2246Imatinib Mesylateimatinib
    0904-6621Imatinib MesylateImatinib Mesylate
    67877-634Imatinib mesylateImatinib mesylate
    67877-633Imatinib mesylateImatinib mesylate
    72485-202Imatinib mesylateImatinib mesylate
    0904-6901Imatinib MesylateImatinib Mesylate
    16714-704imatinib mesylateimatinib mesylate
    16714-705imatinib mesylateimatinib mesylate
    42292-044Imatinib MesylateImatinib Mesylate
    42292-043Imatinib MesylateImatinib Mesylate
    47335-472imatinib mesylateimatinib mesylate
    47335-475imatinib mesylateimatinib mesylate
    50268-426Imatinib MesylateImatinib Mesylate
    50268-427Imatinib MesylateImatinib Mesylate
    51991-376IMATINIB MESYLATEIMATINIB MESYLATE
    51991-377IMATINIB MESYLATEIMATINIB MESYLATE
    60429-926Imatinib MesylateImatinib Mesylate
    60505-2900Imatinib MesylateImatinib Mesylate
    60429-925Imatinib MesylateImatinib Mesylate
    60687-203Imatinib MesylateImatinib Mesylate
    60505-2901Imatinib MesylateImatinib Mesylate
    60687-192Imatinib MesylateImatinib Mesylate
    64679-794Imatinib MesylateImatinib Mesylate
    64679-793Imatinib MesylateImatinib Mesylate
    65162-795Imatinib MesylateImatinib Mesylate
    65162-794Imatinib MesylateImatinib Mesylate
    68180-390IMATINIB MESYLATEIMATINIB MESYLATE
    68180-391IMATINIB MESYLATEIMATINIB MESYLATE
    51407-270Imatinib MesylateImatinib Mesylate
    51407-269Imatinib MesylateImatinib Mesylate
    72606-556Imatinib mesylateImatinib mesylate
    72606-557Imatinib mesylateImatinib mesylate
    0078-0401Gleevecimatinib mesylate
    0078-0649Gleevecimatinib mesylate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.